Clinical Trials
2 trialsNCT05338970 2025-01-31
HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy
Daiichi Sankyo
Phase 3 Active not recruiting
NCT04750083 2021-02-11
HX008 Plus Chemotherapy VS Pembrolizumab Plus Chemotherapy As the First-line Treatment in Participants With Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer
Taizhou Hanzhong biomedical co. LTD
Phase 2/3 Unknown